Sigma denies sweetened buyout bid from Aspen

Sigma Pharmaceuticals denied Australian media reports that Aspen Pharmacare Holdings had boosted its buyout offer for the company to 65 cents per share, or $689 million; Aspen's formal bid made last month was 55 cents per share. Report